Preliminary Results of Restarting Oral Anticoagulant Treatment In Patients with Non-Valvular Atrial Fibrillation Following Intracranial Hemorrhage: A Population-Based Cohort Study

Patients with non-valvular atrial fibrillation (AF) who survive an intracranial hemorrhage (ICH) have an increased risk of ischemic stroke and thromboembolic events (Stroke/SE). An unanswered question is the efficacy and safety of restarting oral anticoagulant treatment (OAC), relative to not restarting in those patients. Our aim was to investigate if restarting OAC among AF patients with an ICH is linked with a lower risk of Stroke/SE and all-cause mortality, but with a small increase in major bleeding compared to not restarting OAC.
Source: Value in Health - Category: International Medicine & Public Health Authors: Source Type: research